These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 310575)

  • 1. Mixed connective tissue disease in children.
    Peskett SA; Ansell BM; Fizzman P; Howard A
    Rheumatol Rehabil; 1978 Nov; 17(4):245-8. PubMed ID: 310575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family.
    Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):433-40. PubMed ID: 310886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. So you suspect mixed connective tissue disease (MCTD). Which tests to perform?
    Gladman DD; Urowitz MB
    Int J Dermatol; 1984; 23(6):392-3. PubMed ID: 6384083
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed connective tissue disease (MCTD)--its immunological characteristics.
    Chorzelski T; Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):779-82. PubMed ID: 312087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibody against extractable nuclear antigen by an enzyme-linked immuno-sorbent assay. Results from patients with rheumatic and internal medical diseases.
    Struckmann J; Worning P; Manthorpe R; Bendixen G
    Allergy; 1985 Aug; 40(6):442-6. PubMed ID: 3876784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does mixed connective tissue disease exist in India?
    Sood A; Kumar A; Pande I; Malaviya AN
    Br J Rheumatol; 1995 Jun; 34(6):539-41. PubMed ID: 7633796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of ribonucleoprotein antibody.
    Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
    Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease].
    Balthazar PA; Gabriel Júnior A; de Oliveira DP; de Oliveira MA; Rosales T; Iglesias SS; Assad RL; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(6):249-53. PubMed ID: 3879739
    [No Abstract]   [Full Text] [Related]  

  • 10. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
    Lemmer JP; Curry NH; Mallory JH; Waller MV
    J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ribonucleoprotein antibodies in inflammatory rheumatic diseases.
    Piirainen H; Gripenberg M; Laitinen O
    Scand J Rheumatol; 1984; 13(2):177-80. PubMed ID: 6610934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop as an in vitro phenomenon.
    Iwatsuki K; Tagami H; Imaizumi S; Ginoza M; Yamada M
    Br J Dermatol; 1982 Dec; 107(6):653-7. PubMed ID: 6756463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
    Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
    Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with arthritis and anti-U1-RNP antibodies: a 10-year follow-up.
    Piirainen HI
    Br J Rheumatol; 1990 Oct; 29(5):345-8. PubMed ID: 2224402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix.
    Fritzler MJ; Ali R; Tan EM
    J Immunol; 1984 Mar; 132(3):1216-22. PubMed ID: 6198384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antinuclear ribonucleoprotein (nRNP) antibody producing cells in peripheral blood lymphocytes from patients with mixed connective tissue disease.
    Nakano K; Tanimoto K; Möroi Y; Miyamoto T
    J Rheumatol; 1985 Oct; 12(5):924-7. PubMed ID: 3910834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Sharp syndrome (mixed connective tissue diseases) (author's transl)].
    Seelig HP
    Immun Infekt; 1981 Nov; 9(6):223-31. PubMed ID: 6978280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.